Companies › CRDF

CARDIFF ONCOLOGY INC (CRDF)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001213037 · EDGAR filings · Updated 2026-07-27

CARDIFF ONCOLOGY INC (CRDF) has reported institutional ownership of 36.0%, with 115 institutional managers holding positions valued at $39.7M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Employee-plan registration (S-8) filed
• 2026-07-16 — Insider transaction reported (Form 4)
• 2026-07-16 — Insider transaction reported (Form 4)
• 2026-07-16 — Current report (8-K) filed
• 2026-07-16 — Prospectus supplement (424B5) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CARDIFF ONCOLOGY INC has 115 institutional holders and institutional ownership of 36.0%.

Insider activity

Insiders reported 2 transactions (2 buys, 0 sells) across 2 reporting insiders, with a net reported value of $710.5K.

Data flags from SEC filings

Related companies

PYXIS ONCOLOGY INC (PYXS) · SERA PROGNOSTICS INC (SERA) · ARMATA PHARMACEUTICALS INC (ARMP) · CANTON STRATEGIC HOLDINGS IN (CNTN) · AUNA S A (AUNA) · GALECTIN THERAPEUTICS (GALT)